person · Reporting owner
Calamari Christopher J.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | SENIOR VICE PRESIDENT | February 28, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 28, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 32,822 |
Reported balance
After 2023-02-28 transaction · row 1
1 source rowRow 1 · 2023-02-28 · Tax withholding · Disposed 2,827 · Balance 32,822 |
| Common shares without par valueSEC Table I · non-derivative | IndirectThe Calamari Family Trust | 30,193 |
Reported balance
Holding disclosure · report date 2023-02-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 30,193 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 103 |
Reported balance
Holding disclosure · report date 2023-02-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 103 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Mar 3, 2023 00:22 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,827 | $99.77 | $282,049.79 |
DisclosureSEC source: 0001415889-23-003896 · form4-03032023_120343.xml · nonDerivative · entry 1 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,822 Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 41,648 | $0.00 Strike: $106.24 | $0.00 |
DisclosureSEC source: 0001415889-23-003047 · form4-02222023_110207.xml · derivative · entry 4 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,648 Underlying: Common Shares · 41,648 shares Expires 2033-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,882 on February 17, 2024, 13,883 on February 17, 2025 and 13,883 on February 17, 2026. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 10,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003047 · form4-02222023_110207.xml · nonDerivative · entry 1 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,649 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 20:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 569 | $108.65 | $61,821.85 |
DisclosureSEC source: 0001415889-22-007180 · form4-07012022_010747.xml · nonDerivative · entry 1 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,089 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 706 | $118.15 | $83,414.11 |
DisclosureSEC source: 0001415889-22-002187 · form4-03022022_040347.xml · nonDerivative · entry 2 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,658 Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,368 | $122.41 | $289,866.88 |
DisclosureSEC source: 0001415889-22-002187 · form4-03022022_040347.xml · nonDerivative · entry 1 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,364 Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 59,708 | $0.00 Strike: $117.58 | $0.00 |
DisclosureSEC source: 0001415889-22-001731 · form4-02232022_050208.xml · derivative · entry 4 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,708 Underlying: Common Shares · 59,708 shares Expires 2032-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,902 on February 18, 2023, 19,903 on February 18, 2024 and 19,903 on February 18, 2025. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 12,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-001731 · form4-02232022_050208.xml · nonDerivative · entry 1 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,732 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 19,291 | $0.00 Strike: $116.40 | $0.00 |
DisclosureSEC source: 0001415889-21-003509 · form4-07062021_020756.xml · derivative · entry 4 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,291 Underlying: Common Shares · 19,291 shares Expires 2031-06-30 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,430 on July 1, 2022, 6,430 on July 1, 2023 and 6,431 on July 1, 2024. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003509 · form4-07062021_020756.xml · nonDerivative · entry 1 Calamari Christopher J. · CIK 0001868518 · SENIOR VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,920 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.